Ozcan Basaran

Özcan Başaran is a cardiologist at the Muğla Sıtkı Koçman University Education and Research Hospital. His research interests focus on atrial fibrillation. He has recently conducted ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey (RAMSES) study. The study aimed to investigate oral anticoagulant use among Turkish atrial fibrillation patients.

1books edited

1chapters authored

Latest work with IntechOpen by Ozcan Basaran

The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists.

Go to the book